NUS · Nu Skin Enterprises, Inc. · Insider Trading

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

The reported transaction occurred pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on November 11, 2025.

The reported transaction occurred pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted on February 19, 2026.

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $12.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.10 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.11 to $12.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.